<DOC>
	<DOCNO>NCT02721472</DOCNO>
	<brief_summary>The purpose study evaluate relationship plasma DNA level micro- macro-circulatory vascular remodelling patient sickle cell disease</brief_summary>
	<brief_title>Plasma DNA Vascular Remodelling Patients With Sickle Cell Disease</brief_title>
	<detailed_description />
	<mesh_term>Anemia , Sickle Cell</mesh_term>
	<mesh_term>Vascular Remodeling</mesh_term>
	<criteria>Age ≥ 18 year . Homozygous SS Sß0 sickle cell disease patient . Seen consultation annual clinical paraclinical evaluation his/her disease . Stable clinical condition disease define absence severe vasoocclusive crisis ( require hospitalisation visit emergency unit ) previous month absence transfusion previous 3 month . Other haemoglobinopathy Known diabetes . Recent administration anticoagulant treatment curative dos ( &lt; 48h inclusion ) , plateletinhibiting drug ( less 1 week prior inclusion ) . Recent transfusion ( le 3 month prior inclusion ) . Pregnancy postpartum ( first 40 day give birth ) . Recent consumption alcohol ( le 10h ) , coffee ( le 3h ) , tobacco ( le 36h ) inclusion . Known infection hepatitis B , C , HIV infection . Known cancer progressive blood disease . Known haemostasis coagulation disorder . Progressive inflammatory infectious disease . Recent history ( date less 3 month ) venous ( pulmonary embolism , deep venous thrombosis ) arterial ( acute coronary syndrome , stroke , peripheral arterial ischaemia ) thromboembolic event . Adult patient subject legal protection measure . Patients already involve therapeutic protocol . Patients affiliate social security system . Noninclusion criterion related technical requirement EndoPAT : Known cardiac arrhythmia . Severe Raynaud 's syndrome . Hand arm deformity prevents EndoPAT analysis .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>